Although it is well known that spinal cord microglia activation plays a causal role in the development of neuropathic pain after peripheral nerve injury (PNI), the mechanisms of this activation have not been completely elucidated. We have previously shown that toll-like receptor 2 (TLR2) is involved in PNI-induced spinal cord microglia activation. A more recent study showed that PNI induces interferon regulatory factor 8 (IRF8), which is a key transcription factor responsible for microglia activation. In this study, we investigated the putative role of TLR2 in IRF8 expression in spinal cord microglia after PNI. In TLR2 knockout mice, nerve injury-induced spinal cord IRF8 expression was severely compromised. In addition, an intrathecal injection of lipoteichoic acid (LTA), a TLR2 agonist, induced IRF8 mRNA expression in the spinal cord. Lastly, TLR2 stimulation by LTA induced IRF8 mRNA expression in primary spinal cord glial cells. TLR2-induced IRF8 expression was dependent on p38 MAPK and NF-κB activation. Taken together, these data show that TLR2 activation induces IRF8 expression in spinal cord microglia after PNI.
Introduction
Peripheral nerve injury (PNI) often results in a pathological pain state known as neuropathic pain, which is characterized by enhanced pain sensations against noxious stimuli (hyperalgesia) and pain induction by non-noxious stimuli (allodynia) [1] . A series of studies have demonstrated that the activation of spinal cord microglia plays critical roles in the development of neuropathic pain after PNI [2] [3] [4] [5] . After PNI, spinal cord microglial cells are activated and increase the expression of pain-mediating genes, such as TNF-α, IL-1β, and BDNF [6, 7] . These molecules facilitate pain hypersensitivity by inducing central sensitization at the spinal cord level.
A recent study showed that interferon regulatory factor 8 (IRF8) functions as a key transcription factor in microglial activation after PNI [8] . In this study, IRF8 overexpression in
BRIEF REPORT
cultured microglia increased the transcription of genes associated with reactive microglia. Introducing IRF8-overexpressing microglia spinally into wild-type (WT) mice led to the development of neuropathic pain. In addition, IRF8-deficient mice showed decreased pain behavior and microglia activation after PNI. Although the vital role of IRF8 in nerve injury-induced spinal cord microglia activation is well characterized, it remains unclear how IRF8 is up-regulated in spinal cord microglia after PNI.
We have previously reported that TLR2 plays a critical role in nerve injury-induced spinal cord microglia activation [9] . PNI-induced microglia activation and subsequent neuropathic pain induction are reduced in TLR2 knockout mice when compared with WT mice. In addition, we previously reported that NADPH oxidase 2 expression is involved in TLR2-mediated spinal cord microglia activation after PNI [10, 11] . These studies suggest that TLRs act as microglial activation receptors that respond to nerve injury; thus, we hypothesized that TLR2 is involved in nerve injury-induced IRF8 expression in spinal cord microglia, and we tested this hypothesis using TLR2 knockout mice.
Materials and Methods

Animals
All surgical and experimental procedures were reviewed and approved by the Institutional Animal Care and Use Committee at Seoul National University. The animal treatments were performed in accordance with the guidelines of the International Association for the Study of Pain. All mice were housed in an animal facility with a specific pathogen-free barrier, a temperature of 23 ± 2 °C, and a 12-h light-dark cycle. Animals received food and water ad libitum. TLR2 knockout mice on a C57BL/6 background and WT C57BL/6 mice aged 8-10 weeks were used for the experiments. TLR2 knockout mice were kindly provided by Dr. S. Akira (Osaka University, Japan) [12] and WT C57BL/6 mice were purchased from Daehan Biolink (Eumsung, Korea).
Neuropathic pain model
PNI was induced by transecting the L5 spinal nerve (L5 SNT) under anesthesia with sodium pentobarbital (50 mg/kg, i.p.) as previously described [10] . Briefly, an incision was made to the skin above the spinal processes at the L4-S2 level. The paraspinal muscles were separated, and the L6 transverse process was partially removed. Next, the L5 spinal nerve was carefully separated and transected. The wound was irrigated with 10% povidone-iodine and closed in two layers using surgical staples. The sham operation was performed as described above but without the transection of the L5 spinal nerve. After the procedure, mice were monitored on a warm pad until recovery from anesthesia.
Immunohistochemistry
Mice were deeply anesthetized with sodium pentobarbital (70 mg/kg, i.p.) and then transcardially perfused with 4% PFA in 0.1M phosphate buffer (pH 7.4). The spinal cord was removed via laminectomy, post fixed at 4°C overnight, and transferred to 30% sucrose in phosphate buffer for 48 h. Transverse spinal cord sections (14-µm thick) were prepared on gelatin-coated slide glass using a Cryocut Microtome. The sections were blocked with a solution containing 5% normal donkey serum (Jackson ImmunoResearch, Bar Harbor, ME, USA), 2% BSA (Sigma, St. Louis, MO, USA), and 0.1% Triton X-100 (Sigma) for 1 h at room temperature. The sections were then incubated overnight at 4°C with primary antibodies for rabbit anti-Iba-1 (1:2,000, Wako, Osaka, Japan) and goatanti-IRF8 (1:200, Santa Cruz Biotechnology, CA, USA). The sections were then incubated for 1 h at room temperature with a mixture of FITC-conjugated and Cy3-conjugated secondary antibodies (1:200, Jackson ImmunoResearch). The sections were mounted, and fluorescent images were obtained using a confocal microscope (LSM700, Carl Zeiss, Germany).
Primary cell culture
Primary rat spinal cord glial cells were obtained from 7-day-old Sprague-Dawley rats according to previously established procedures [9] . Briefly, the spines of anesthetized rats were removed beginning at 0.5 cm above the tail, a syringe with phosphate-buffered saline was inserted, and the spinal cord was pushed out with hydraulic pressure. After removal of the meninges, the spinal cord was triturated with repetitive pipetting and seeded in 75-cm 2 flasks. Cells were cultured in Dulbecco's modified Eagle medium supplemented with 10 mM HEPES, 10% fetal bovine serum, 2 mM L-glutamine, and a 1× antibiotic/antimycotic. After 2 weeks, the glial cells were trypsinized and seeded in 6-well plates for subsequent use.
Real-time RT-PCR
Real-time RT-PCR was performed using SYBR Green PCR Master mixture and ABI Prism 7500 sequence detection system (Applied Biosystems, Foster City, CA, USA). The following PCR primer sequences were used: mouse/rat GAPDH (forward), 5ʹ-AGG TCA TCC CAG AGC TGA ACG-3ʹ; mouse/rat GAPDH (reverse), 5ʹ-CAC CCT GTT GCT GTA GCC GTA T-3ʹ; rat IRF8 (forward), 5ʹ-CGC ACA CCA TTC AGC CTT ATC CCA G-3ʹ; rat IRF8 (reverse), 5ʹ-TGG TGA CTG GGT ATA CTG CCT ATG-3ʹ; mouse IRF8 (forward), 5ʹ-GGA TAT GCC GCC TAT GAC ACA-3ʹ; and mouse IRF8 (reverse), 5ʹ-CAT CCG GCC CAT ACA ACT TAG-3ʹ. The level of each gene was normalized to the corresponding level of GAPDH and represented as a fold change using the 2 −ΔΔCT method [13] . All real-time RT-PCR experiments were performed at least three times, and the mean ± SEM values are presented unless otherwise noted.
Intrathecal lipoteichoic acid (LTA) injection
Under sodium pentobarbital anesthesia (25 mg/kg, i.p.), mice were injected with LTA via a direct lumbar puncture between the L5 and L6 vertebrae using a 10 µl Hamilton syringe (Hamilton Company, Reno, NV, USA) with a 30 gauge 0.5-inch needle [14] . A total of 5 µl of 50 µg/ml LTA in saline or saline alone was intrathecally injected in WT and TLR2 knockout mice. LTA was preincubated with polymyxin B (10 µg/ml) for 30 min at 37 °C before use to prevent LPS contamination. The success of the intrathecal injection was assessed by monitoring the tail-flicking response of the animal when the needle penetrated the subarachnoid space.
Statistics
The statistical significance of differences was assessed using SigmaPlot software (version 11.0, Systat Software, Inc., San Jose, CA, USA). Statistical analyses were performed using Student's t-tests. All data are presented as the mean ± SEM, and differences were considered statistically significant when the p-value was less than 0.05.
Results
IRF8 upregulation after nerve injury is inhibited in TLR2 knockout mice
To test the putative role of TLR2 in IRF8 expression in the spinal cord after PNI, we induced a L5 SNT injury in WT and TLR2 knockout mice and measured IRF8 mRNA expression in the L4-5 spinal cord. IRF8 mRNA expression increased up to 2.7-fold in WT mice 3 days after SNT, whereas SNT-induced IRF8 mRNA upregulation was inhibited by 86% in TLR2 knockout mice (Fig. 1A) . IRF8 immunoreactivity (IR) was detected in the ipsilateral dorsal horn after SNT (Fig. 1B) . The IRF8-IR signals are mostly colocalized with Iba-1-positive microglia. However, IRF8-IR in the ipsilateral dorsal horn and microglial activation was significantly reduced in TLR2 knockout mice when compared with WT mice. These data demonstrate that TLR2 is required for optimal IRF8 expression after SNT.
TLR2 activation induces IRF8 expression in spinal cord microglia
To test if TLR2 signaling directly activates IRF8 gene expression, we stimulated primary spinal cord glial cells with LTA, a TLR2 agonist. LTA stimulation induced a greater than 8-fold increase in IRF8 transcription (Fig. 2A) . It is well known that p38 MAP kinase and NF-κB mediate nerve injury-induced spinal cord microglial activation and subsequent pain central sensitization [15, 16] . We tested the involvement of these signaling molecules in the TLR2-induced IRF8 expression using pharmacological inhibitors. Helenalin, a NF-κB inhibitor, completely blocked the TLR2-induced IRF8 mRNA induction (Fig. 2B) . Similarly, SB202190, a p38 inhibitor, inhibited IRF8 induction by 63%. In addition, an intrathecal injection of LTA induced a 2.5-fold increase in IRF8 transcription in spinal cord tissue (Fig. 2C ).
Discussion
It is well known that microglia activation in the spinal cord plays a causal role in the development of neuropathic pain after PNI. Furthermore, previous studies showed that IRF8 is a key transcription factor for microglial activation after PNI. The activation of IRF8 induces IRF5 transcription, which then induces P2rx4 gene expression [17] . Microglial P2X4 receptor activation by ATP released from the spinal cord dorsal horn neurons [18] during nerve injury leads to BDNF release, which causes central sensitization of pain by shifting intracellular Cl − concentrations in pain-mediating spinal cord neurons [6, 19] . Thus, IRF8-IRF5-P2X4-BDNF axis was proposed as the signaling pathway in spinal cord microglia responsible for nerve injury-induced neuropathic pain. However, it remains unclear how PNI induces IRF8 expression in spinal cord microglia. Current literature suggests that ATP released from dorsal horn neurons or excess glutamate release from injured nerves into the dorsal horn may trigger spinal cord microglial activation [18, 20] . However, in our study, neither ATP nor glutamate induced IRF8 in spinal cord microglia in vitro (data not shown). Thus, it is unlikely that these molecules function as triggers for spinal cord microglia activation.
In this study, by using TLR2 knockout mice, we demonstrated for the first time that TLR2 signaling is required for IRF8 expression after PNI. Our data suggest that TLR2 signaling in the spinal cord leads to IRF8 expression after PNI. Notably, it is also possible that TLR2 signaling in the peripheral immune cells may indirectly affect IRF8 expression in spinal cord microglia. However, the results of an intrathecal LTA administration, in which spinal cord cells but not peripheral immune cells are involved, suggest that TLR2 activation in spinal cord cells induces IRF8 expression in microglia. This hypothesis is further supported by our in vitro data showing that LTA-mediated TLR2 activation successfully upregulated IRF8 transcription in primary cultured spinal cord glia. In the spinal cord in vivo, TLR2 is mainly expressed in microglia [11] . Based on these data, it is reasonable to speculate that TLR2 activation on microglia induces IRF8 expression and thus triggers pain-mediating microglia activation after PNI. This model is based on the assumption that a specific TLR2 endogenous agonist is released in the spinal cord dorsal horn after PNI; however, this agonist remains undiscovered. Previous studies have identified various endogenous TLR2 agonists, including heat shock proteins, high mobility group box-1, and hyaluronic acid [21] . Therefore, it is important to assess the role of these endogenous TLR2 agonists in the development of nerve injury-induced neuropathic pain in future studies.
In conclusion, we found that TLR2 is required for IRF8 expression in spinal cord microglia after PNI. This finding suggests that the TLR2-IRF8 signaling pathway may serve as a triggering event for microglia activation after PNI.
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